Evidence map›Paper›PMID 36339447›Full record

ArticleFrontiers in endocrinology2022

Leptin receptor antagonist attenuates experimental autoimmune thyroiditis in mice by regulating Treg/Th17 cell differentiation.

Wei Wang, Bo-Tao Zhang, Qi-Lan Jiang, Han-Qing Zhao, Qin Xu, Yang Zeng, Jia-Ying Xu, Jun Jiang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Obesity and leptin in breast cancer angiogenesis.Frontiers in endocrinology · 2024
    Review
  15. Article
  16. Article
  17. The Role of Adipokines in the Pathogenesis of Psoriasis.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wei WangDepartment of General Surgery (Thyroid Surgery), the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Bo-Tao ZhangDepartment of General Surgery (Thyroid Surgery), the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Qi-Lan JiangDepartment of Clinical Nutrition, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Han-Qing ZhaoDepartment of General Surgery (Thyroid Surgery), the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Qin XuDepartment of General Surgery (Thyroid Surgery), the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yang ZengDepartment of Orthodontics, the Affiliated Stomatological Hospital of Southwest Medical University, Luzhou, China.
Jia-Ying XuDepartment of General Surgery (Thyroid Surgery), the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jun JiangDepartment of General Surgery (Thyroid Surgery), the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Affiliated Hospital of Southwest Medical University · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptin has been found to be involved in the development and progression of many autoimmune diseases. As an organ-specific autoimmune disease, the pathogenesis of Hashimoto's thyroiditis has not been fully elucidated. It has been reported that serum leptin level is increased in Hashimoto's thyroiditis, but other studies have not shown any difference. We replicated a mouse model of experimental autoimmune thyroiditis (EAT) with a high-iodine diet and found that injection of the leptin receptor antagonist Allo-aca reduced thyroid follicle destruction and inflammatory cell infiltration in EAT mice, and thyroxine and thyroid autoimmune antibody levels. Further investigation revealed that Allo-aca promotes the differentiation of Treg cells and inhibits the differentiation of Th17 cells. We believe that Allo-aca can alter the differentiation of Treg/Th17 cells by inhibiting the leptin signaling pathway, thereby alleviating thyroid injury in EAT mice. Interfering with the leptin signaling pathway may be a novel new approach to treat treating and ameliorating Hashimoto's thyroiditis.

Indexed as

Autoimmune DiseasesHashimoto DiseaseThyroiditis, AutoimmuneAnimalsCell DifferentiationLeptinMiceReceptors, LeptinTh17 CellsT-Lymphocytes, RegulatoryLeptinReceptors, Leptinexperimental autoimmune thyroiditis (EAT)JAK2/STAT3 pathwayleptinleptin receptor antagonistNOD/ShiLtJ mouse

Identifiers

PMID36339447
PMCPMC9630560
OpenAlexW4306930553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.